Lipoprotein(a) & Apolipoprotein B: What Your Cholesterol Panel Might Miss
A standard cholesterol test doesn't always tell the whole story. Two additional blood markers — Lipoprotein(a), or Lp(a), and Apolipoprotein B, or ApoB — are drawing new attention in national heart-health guidelines because they can reveal heart disease risk that routine testing can miss.
Lp(a) is a cholesterol-carrying particle whose level is set almost entirely by your genes — diet, exercise, and weight loss have little effect on it. A high Lp(a) raises the risk of heart attack and stroke on its own, separate from your regular cholesterol numbers, which is why it's sometimes called a "hidden" risk factor.
Apolipoprotein B — ApoB
ApoB is a protein found on every particle that can build up in artery walls, including LDL ("bad" cholesterol). Measuring ApoB counts the actual number of these particles circulating in your blood, which some experts consider a more precise risk marker than the LDL number alone.
Who should ask about testing
Anyone with a family history of early heart attack or stroke (generally before about 55 in male relatives or 65 in female relatives)
Anyone with a personal history of heart disease, stroke, or peripheral artery disease
Anyone whose cholesterol runs high despite a healthy diet and regular exercise
Anyone whose overall heart disease risk is unclear after a standard lipid panel
A major update to the national cholesterol management guideline recommends that every adult have Lp(a) checked at least once, regardless of family history, since it is common and often goes undetected by routine testing alone.
Understanding your results
Lab reports use different units and reference ranges, and the "right" target depends on your overall risk profile — your clinician is best positioned to interpret your specific numbers. As general reference points:
Lp(a): current national guidance treats a level at or above roughly 125 nmol/L (about 50 mg/dL) as a risk-enhancing factor that supports more attention to your other heart disease risk factors.
ApoB: professional groups suggest lower targets for people at higher overall cardiovascular risk — generally somewhere in the range of 90 mg/dL down to 60–65 mg/dL depending on your individual risk category.
What can — and can't — be changed
Lp(a) is mostly determined by genetics, so diet and exercise won't meaningfully lower it, and it isn't significantly affected by statins. Knowing it's elevated is still useful: it helps your clinician manage the risk factors that are modifiable — blood pressure, LDL cholesterol, smoking, and diabetes — more aggressively. Newer Lp(a)-lowering medications are currently being studied in clinical trials.
ApoB, by contrast, generally moves together with LDL cholesterol — statins, other lipid-lowering medications, and lifestyle changes such as diet, exercise, and weight management that lower LDL typically lower ApoB as well.
Sources: 2026 ACC/AHA Guideline on the Management of Dyslipidemia and National Lipid Association expert consensus on apolipoprotein B. This information is educational and does not replace an individual medical evaluation — ask your Central Medical Associates clinician whether Lp(a) or ApoB testing is right for you.